Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00310219 · ClinicalTrials.gov registry record · NA
Positron Emission Tomography Scan and CT Scan in Planning Radiation Therapy for Patients With Stage II or Stage III Non-Small Cell Lung Cancer
A NA study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT00310219 is a NA study that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 52 participants.
The verdict
NCT00310219, a NA study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
RATIONALE: Imaging procedures, such as positron emission tomography (PET) scan and CT scan, may help doctors plan radiation therapy for patients with non-small cell lung cancer. PURPOSE: This clinical trial is studying how well a combined PET scan and CT scan works compared to a CT scan alone in planning radiation therapy for patients with stage II or stage III non-small cell lung cancer.
Interventions
- PROCEDURE positron emission tomography
- PROCEDURE computed tomography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2006-02 |
| Est. Completion | 2013-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00310219
The ClinicalTrials.gov registry entry for NCT00310219 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which positron emission tomography is the first listed.
NCT00310219 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00310219 about?
NCT00310219 is a clinical study titled "Positron Emission Tomography Scan and CT Scan in Planning Radiation Therapy for Patients With Stage II or Stage III Non-Small Cell Lung Cancer". RATIONALE: Imaging procedures, such as positron emission tomography (PET) scan and CT scan, may help doctors plan radiation therapy for patients with non-small cell lung cancer. PURPOSE: This clinical trial is studying how well a combined PET scan and CT scan works compared to a CT scan alone in pl...
What is the current status of trial NCT00310219?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2006-02. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00310219?
The interventions under investigation include: positron emission tomography (PROCEDURE), computed tomography (PROCEDURE).
Who is sponsoring clinical trial NCT00310219?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.